Does AMIODARONE Cause Benign prostatic hyperplasia? 36 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Benign prostatic hyperplasia have been filed in association with AMIODARONE (Amiodarone Hydrochloride). This represents 0.1% of all adverse event reports for AMIODARONE.
36
Reports of Benign prostatic hyperplasia with AMIODARONE
0.1%
of all AMIODARONE reports
23
Deaths
34
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From AMIODARONE?
Of the 36 reports, 23 (63.9%) resulted in death, 34 (94.4%) required hospitalization, and 20 (55.6%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIODARONE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does AMIODARONE Cause?
Drug ineffective (2,223)
Dyspnoea (2,182)
Off label use (1,608)
Drug interaction (1,589)
Asthenia (1,452)
Interstitial lung disease (1,421)
Hyperthyroidism (1,410)
Fatigue (1,269)
Bradycardia (1,261)
Atrial fibrillation (1,211)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which AMIODARONE Alternatives Have Lower Benign prostatic hyperplasia Risk?
AMIODARONE vs AMISULPRIDE
AMIODARONE vs AMITRIPTYLINE
AMIODARONE vs AMITRIPTYLINE\PERPHENAZINE
AMIODARONE vs AMIVANTAMAB
AMIODARONE vs AMIVANTAMAB-VMJW